A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab.

Naoki, Katsuhiko; Takeda, Yuichiro; Soejima, Kenzo; Arai, Daisuke; Naka, Go; Nagase, Seisuke; Arimura, Ken; Kanemura, Toshinori; Ohhira, Tatsuo; Ikeda, Norihiko

Naoki, Katsuhiko; Takeda, Yuichiro; Soejima, Kenzo; Arai, Daisuke; Naka, Go; Nagase, Seisuke; Arimura, Ken; Kanemura, Toshinori; Ohhira, Tatsuo; Ikeda, Norihiko.

Afiliación

Naoki K; Cancer Center, Keio University School of Medicine, Tokyo 160-8582, Japan.
Takeda Y; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Soejima K; Shinjuku Thoracic Oncology Group, Tokyo 160-8582, Japan.
Arai D; Shinjuku Thoracic Oncology Group, Tokyo 160-8582, Japan.
Naka G; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Nagase S; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Arimura K; Shinjuku Thoracic Oncology Group, Tokyo 160-8582, Japan.
Kanemura T; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Ohhira T; Shinjuku Thoracic Oncology Group, Tokyo 160-8582, Japan.
Ikeda N; Shinjuku Thoracic Oncology Group, Tokyo 160-8582, Japan.

Oncol Lett ; 13(5): 3285-3290, 2017 May.

Article en En | MEDLINE | ID: mdl-28521435

Palabras clave

bevacizumab; cohort study; endothelial growth factor receptor; non-small-cell lung cancer; prospective

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google